Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Roche Holding (0TDF) Share Price & Analysis

0 Followers

0TDF Stock Chart & Stats

$60.87$0.00(0.00%)
At close: 4:30 PM GMT
$52.5$55$57.5$60Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$60.12 - $60.29
52-Week Range
$44.90 - $61.36
Previous Close
$60.87
Volume
N/A
Average Volume (3M)
13.46K
Market Cap
$386.79B
Enterprise Value
$363.86B
Total Cash (Recent Filing)
$9.70B
Total Debt (Recent Filing)
$31.69B
Price to Earnings (P/E)
26.3
Beta
0.98
Next Earnings
Jan 28, 2027 (Est.)
EPS Estimate
1.47
Next Dividend Ex-Date
N/A
Dividend Yield
2.58%

Bulls Say, Bears Say

Bulls Say

High Profitability And Cash Generation

Roche combines high gross and operating margins with consistently positive free cash flow, indicating a strong economic model and meaningful internal funding capacity. This supports continued investment in research, launches and commercial infrastructure while providing resilience across the next several quarters.

Pipeline And Regulatory Momentum

Multiple priority reviews and positive late-stage trial results strengthen Roche’s ability to replenish revenue as established products mature. A broad, advancing pipeline can diversify future growth, improve launch visibility and reinforce the company’s position in complex therapeutic areas.

Expanding Medicines And Diagnostics Portfolio

Organic sales growth alongside progress toward new medicines and a differentiated Alzheimer’s blood test demonstrates ongoing portfolio development across both core businesses. These advances can broaden Roche’s addressable markets and strengthen future commercial opportunities beyond existing franchises.

Bears Say

Meaningful Leverage

Although leverage improved, Roche’s financing mix still provides less balance-sheet cushion than more conservatively funded peers. Higher debt relative to equity can constrain flexibility for acquisitions, shareholder distributions and research investment if earnings or cash generation weaken.

Uneven Revenue Growth

The uneven historical top-line pattern makes it harder to establish that recent growth will compound steadily. Volatility across years may reflect changing product demand and market conditions, requiring Roche to rely on successful launches and pipeline conversion to sustain momentum.

Competitive And Biosimilar Pressure

Biosimilar entry and competitive pressure in established franchises can erode sales and pricing power as products mature. These effects may persist beyond a single quarter, increasing the importance of replacement launches and successful lifecycle management to protect the revenue base.

Roche Holding News

0TDF FAQ

What was Roche Holding’s price range in the past 12 months?
Roche Holding lowest share price was $44.90 and its highest was $61.36 in the past 12 months.
What is Roche Holding’s market cap?
Roche Holding’s market cap is $386.79B.
When is Roche Holding’s upcoming earnings report date?
Roche Holding’s next earnings report is estimated for Jan 28, 2027 (not yet confirmed), which is in 75 days.
How were Roche Holding’s earnings last quarter?
Roche Holding released its earnings results on Jul 23, 2026. The company reported $1.661 earnings per share for the quarter, beating the consensus estimate of $1.601 by $0.06.
Is Roche Holding overvalued?
According to Wall Street analysts Roche Holding’s price is currently Overvalued.
Does Roche Holding pay dividends?
Roche Holding does not currently pay dividends.
What is Roche Holding’s EPS estimate?
Roche Holding’s EPS estimate is 1.47.
How many shares outstanding does Roche Holding have?
Roche Holding has 5,620,501,500 shares outstanding.
What happened to Roche Holding’s price movement after its last earnings report?
Roche Holding reported an EPS of $1.661 in its last earnings report, beating expectations of $1.601. Following the earnings report the stock price went up 4.758%.
Which hedge fund is a major shareholder of Roche Holding?
Hedge funds hold Roche Holding shares: the largest hedge-fund position in Roche Holding is 650,314,010 shares, and hedge funds decreased their holdings by 3.5K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology